Australia · Delayed Price · Currency is AUD Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of AUD 14.21 billion. The enterprise value is 13.99 billion.
| Market Cap | 14.21B |
| Enterprise Value | 13.99B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Feb 26, 2026 |
Share Statistics
Pro Medicus has 104.47 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 104.47M |
| Shares Outstanding | 104.47M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 48.70% |
| Owned by Institutions (%) | 19.11% |
| Float | 53.00M |
Valuation Ratios
The trailing PE ratio is 60.64 and the forward PE ratio is 80.76. Pro Medicus's PEG ratio is 2.79.
| PE Ratio | 60.64 |
| Forward PE | 80.76 |
| PS Ratio | 59.06 |
| PB Ratio | 36.53 |
| P/TBV Ratio | 38.72 |
| P/FCF Ratio | 111.55 |
| P/OCF Ratio | 111.14 |
| PEG Ratio | 2.79 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 77.86, with an EV/FCF ratio of 109.83.
| EV / Earnings | 59.60 |
| EV / Sales | 58.15 |
| EV / EBITDA | 77.86 |
| EV / EBIT | 78.36 |
| EV / FCF | 109.83 |
Financial Position
The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.22 |
| Quick Ratio | 6.06 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 76.80% and return on invested capital (ROIC) is 74.09%.
| Return on Equity (ROE) | 76.80% |
| Return on Assets (ROA) | 26.95% |
| Return on Invested Capital (ROIC) | 74.09% |
| Return on Capital Employed (ROCE) | 36.83% |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | 1.82M |
| Profits Per Employee | 1.78M |
| Employee Count | 132 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 4.12 |
Taxes
In the past 12 months, Pro Medicus has paid 98.65 million in taxes.
| Income Tax | 98.65M |
| Effective Tax Rate | 29.59% |
Stock Price Statistics
The stock price has decreased by -35.48% in the last 52 weeks. The beta is 0.56, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -35.48% |
| 50-Day Moving Average | 127.89 |
| 200-Day Moving Average | 230.29 |
| Relative Strength Index (RSI) | 51.40 |
| Average Volume (20 Days) | 337,001 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of AUD 240.57 million and earned 234.70 million in profits. Earnings per share was 2.24.
| Revenue | 240.57M |
| Gross Profit | 240.25M |
| Operating Income | 178.53M |
| Pretax Income | 333.34M |
| Net Income | 234.70M |
| EBITDA | 178.91M |
| EBIT | 178.53M |
| Earnings Per Share (EPS) | 2.24 |
Balance Sheet
The company has 221.82 million in cash and 2.55 million in debt, with a net cash position of 219.27 million or 2.10 per share.
| Cash & Cash Equivalents | 221.82M |
| Total Debt | 2.55M |
| Net Cash | 219.27M |
| Net Cash Per Share | 2.10 |
| Equity (Book Value) | 388.93M |
| Book Value Per Share | 3.72 |
| Working Capital | 256.99M |
Cash Flow
In the last 12 months, operating cash flow was 127.84 million and capital expenditures -470,000, giving a free cash flow of 127.37 million.
| Operating Cash Flow | 127.84M |
| Capital Expenditures | -470,000 |
| Depreciation & Amortization | 380,000 |
| Net Borrowing | -745,000 |
| Free Cash Flow | 127.37M |
| FCF Per Share | 1.22 |
Margins
Gross margin is 99.87%, with operating and profit margins of 74.21% and 97.56%.
| Gross Margin | 99.87% |
| Operating Margin | 74.21% |
| Pretax Margin | 138.56% |
| Profit Margin | 97.56% |
| EBITDA Margin | 74.37% |
| EBIT Margin | 74.21% |
| FCF Margin | 52.94% |
Dividends & Yields
This stock pays an annual dividend of 0.64, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 0.64 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 31.91% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 24.49% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.42% |
| Earnings Yield | 1.65% |
| FCF Yield | 0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 120.15 and a Piotroski F-Score of 4.
| Altman Z-Score | 120.15 |
| Piotroski F-Score | 4 |